These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10707580)

  • 1. [Genetic diagnosis and cardiovascular diseases].
    Morita H; Nagai R
    Nihon Rinsho; 2000 Feb; 58(2):485-94. PubMed ID: 10707580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic predisposition to cardiovascular diseases].
    Stajszczyk M; Gmiński J
    Przegl Lek; 2000; 57(1):48-51. PubMed ID: 10907371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of DNA polymorphism in the renin-angiotensin system and the pathogenesis of cardiovascular diseases].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1997; 51(2):171-83. PubMed ID: 9235564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New biochemical and genetic risk factors for coronary artery diseases].
    Imai Y; Nagai R
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():775-80. PubMed ID: 12735065
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics.
    Hoffmann IS; Tavares-Mordwinkin R; Castejon AM; Alfieri AB; Cubeddu LX
    J Hum Hypertens; 2005 Mar; 19(3):233-40. PubMed ID: 15565175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic polymorphism of the renin-angiotensin system and cardiovascular diseases].
    Castellano M; Agabiti-Rosei E
    Cardiologia; 1997 Aug; 42(8):803-13. PubMed ID: 9312407
    [No Abstract]   [Full Text] [Related]  

  • 7. [The genetic component of coronary risk. II].
    Carluccio M; Vanuzzo D; Pilotto L; Fioretti P; Quadrifoglio F; Diviacco S; Mariani M; De Caterina R
    Cardiologia; 1999 Feb; 44(2):155-67. PubMed ID: 10208052
    [No Abstract]   [Full Text] [Related]  

  • 8. [Genetic markers of hypertension].
    Chistiakov DA; Turakulov RI
    Genetika; 1999 May; 35(5):565-73. PubMed ID: 10495944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
    Francis SC; Raizada MK; Mangi AA; Melo LG; Dzau VJ; Vale PR; Isner JM; Losordo DW; Chao J; Katovich MJ; Berecek KH
    Physiol Genomics; 2001 Dec; 7(2):79-94. PubMed ID: 11773594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic polymorphism of coagulation factors as a cardiovascular risk factor].
    Iacoviello L; Donati MB
    Minerva Cardioangiol; 1999 Nov; 47(11):401-2. PubMed ID: 10641411
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polymorphic markers of vasoactive hormones genes and progression of renal diseases].
    Kamyshova ES; Nosikov VV; Kutyrina IM
    Ter Arkh; 2003; 75(6):79-84. PubMed ID: 12920967
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular diseases and molecular variants of the renin-angiotensin system components in Slovak population.
    Jurkovicova D; Sedlakova B; Riecansky I; Goncalvesova E; Penesova A; Kvetnansky R; Krizanova O
    Gen Physiol Biophys; 2007 Mar; 26(1):27-32. PubMed ID: 17579251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphisms in cardiovascular diseases. The experience in the National Institute of Cardiology "Ignacio Chávez"].
    Vargas Alarcón G
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-88-93. PubMed ID: 18938704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between genetic polymorphisms and disease, illustrated by the renin-angiotensin-aldosterone system and cardiovascular disease].
    Spiering W; Kroon AA; Vreugdenhil HA; Geraedts JP; Daemen MJ; de Leeuw PW
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1445-50. PubMed ID: 9752056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphism of the renin-angiotensin-aldosterone system: molecular and epidemiogenetic aspects].
    Soubrier F
    Nephrologie; 1998; 19(7):377-84. PubMed ID: 9857371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analyses of genetic risk factors associated to chronic nephropathy of renal transplant: genetic polymorphisms of cytokynes, adhesion molecules, platelet-coagulation system and cardiovascular risk markers].
    Cobo M; Barrios Y; Iñigo P; Bigo C; Alvarez A; Martín B; Campistol JM; Hernández D; Salido E; Torres A
    Nefrologia; 2004; 24 Suppl 4():49-56. PubMed ID: 15279387
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic determinants of cardiovascular disease: the renin-angiotensin-aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors.
    Gluba A; Banach M; Mikhailidis DP; Rysz J
    In Vivo; 2009; 23(5):797-812. PubMed ID: 19779116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental genetic modifications in the renin-angiotensin and kallikrein-kinin systems: significance for understanding cardiovascular regulation and study of genetic determinism of human diseases].
    Meneton P; Alhenc-Gelas F
    Nephrologie; 1998; 19(7):385-9. PubMed ID: 9857372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymorphic minisatellite of ecNOS4a/4b in the endothelial NO-synthase gene amd cardiovascular diseases].
    Voron'ko OE; Chistiakov DA; Kobalava ZhD; Tereshchenko SN; Moiseev SV; Nosikov VV
    Mol Biol (Mosk); 2000; 34(5):875-8. PubMed ID: 11033815
    [No Abstract]   [Full Text] [Related]  

  • 20. [Genes and cardiovascular diseases].
    Kwiecień J; Skrobowski A; Cholewa M
    Pol Merkur Lekarski; 2004 Jun; 16(96):507-12. PubMed ID: 15510884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.